Laboratoire d'Ingénierie des Protéines et Contrôle Métabolique, Département de Biologie des Génomes, Institut Jacques-Monod, UMR 7592 CNRS-Universités Paris 6 and 7, 2 Place Jussieu, F-75251 Paris cedex 05, France
Received 1 December 2004/ Returned for modification 18 January 2005/ Accepted 25 April 2005
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Aft1 is located in the cytosol of cells grown under iron-replete conditions, but in cells grown under iron-depleted conditions, it is in the nucleus, where it binds to DNA and activates transcription (39). Cells lacking AFT1 grow poorly under iron-depleted conditions (3, 29, 37). Consistent with this phenotype, Aft1 activates the transcription of genes involved in iron uptake at the plasma membrane. These include genes that encode the high-affinity ferrous transport complex composed of the multicopper oxidase (FET3) and iron permease (FTR1) (1, 34), the copper transporter responsible for delivering copper to Fet3 (CCC2) (40), plasma membrane metalloreductases (FRE1 to FRE4) (5, 10, 41), iron-siderophore transporters (ARN1 to ARN4) (17, 18, 42, 43), and cell wall mannoproteins, which facilitate the uptake of siderophore-bound iron (FIT1 to FIT3) (25). Aft1 is also involved in the activation of other genes, such as FTH1, which encodes a vacuolar iron transporter (35), and genes with functions not yet elucidated in iron metabolism, such as HMX1, the homolog of the gene encoding heme oxygenases (26, 33), two members of the FRE family (FRE5 and FRE6) (21), and CTH2, a gene recently shown to be involved in mRNA degradation under iron deficiency (27). Others genes were recently shown by DNA microarray analyses to be regulated by the constitutive AFT1-1up mutant allele, but the role of Aft1 in their regulation remains to be elucidated (30, 33).
The role of Aft2 is still unclear, unlike that of Aft1. No phenotype is associated with the lack of AFT2 alone. Consistent with this lack of phenotype, the genes involved in the iron uptake systems are expressed similarly in the wild type and in the aft2
mutant (3; unpublished results). However, plasmids expressing AFT2 in the aft1 aft2 mutant activate the transcription of Aft1 target genes in an iron-regulated manner (3, 29). The deletion of AFT2 exacerbates the phenotype of the aft1 mutant, rendering the aft1 aft2 double mutant unable to grow under iron-depleted conditions, and it abolishes the residual transcription of genes such as FET3 and CTH2 that still occurs in the single aft1 mutant (3, 27). The aft1 aft2 mutant also has many oxidative stress-related phenotypes that are not present in the aft1 mutant (3). These results suggested that the roles of Aft2 and Aft1 overlap to some extent.
DNA microarray data have defined a set of genes that is activated by the constitutive AFT2-1up (29, 30). A few of these genes encode proteins that are involved in iron homeostasis, such as the vacuolar iron transporter SMF3 (23, 24), the mitochondrial iron transporter MRS4 (7), and a protein involved in the mitochondrial iron-sulfur cluster assembly, ISU1 (9, 32). This work was designed to define the involvement of Aft1 and Aft2 in the transcriptional regulation of iron homeostasis in regard to the presence/absence of the paralog. DNA microarray clustering allowed us to identify several classes of genes that are regulated by Aft1 and/or Aft2, and computer analyses highlighted different consensus sequences for each class. A combination of Northern blotting and chromatin immunoprecipitation experiments with the iron-regulated genes FET3, FTR1, SMF3, and MRS4 demonstrated that the direct transcription activation mediated by either Aft1 or Aft2 is gene specific and iron dependent. Aft2 directly activates the transcription of the iron intracellular use genes SMF3 and MRS4, while Aft1 does not. We show that Aft2 functions in the absence of Aft1. We have also obtained evidence that the amounts of Aft1 and Aft2 are increased in the absence of the paralog and that iron represses the amounts of Aft1 and Aft2 in these genetic contexts.
| MATERIALS AND METHODS |
|---|
|
|
|---|
. The strains used for other experiments were derivatives from strains obtained from Research Genetics (Huntsville, AL). The haploid strain SCMC01 (aft1
aft2
) was constructed as follows. Y01090 and Y14438 were mated, and the diploid strain was selected on medium lacking lysine and methionine and was made to sporulate. Tetrads were dissected, and spores showing resistance to Geneticin and hypersensitivity to copper were characterized. AFT1 and AFT2 deletions were verified by PCR, and the known phenotypes of the Y18aft2
double mutant strain (3) were confirmed. Strains SCMC05 (AFT2, AFT1-HA), SCMC11, SCMC18 (AFT1, AFT2-HA), SCMC10 (aft2
, AFT1-HA), and SCMC13 (aft1
, AFT2-HA) carry three tandem copies of the influenza virus hemagglutinin (HA) epitope at the very carboxy terminus of AFT1 or AFT2. The HA epitope tags for AFT1 and AFT2 were amplified from the template pFA6a-3HA-HIS3MX6 as described previously (20), using the following primer sets: AFT1-3HA, 5'-AATGGTGAACGGCGAGTTGAAGTATGTGAAGCCAGAAGATCGGATCCCCGGGTTAATTAA-3' and 5'-ATGGACGAGAGATACGTCTAAGTTTGATTTCATCTATATGGAATTCGAGCTCGTTTAAAC-3'; AFT2-3HA, 5'-TGAATTAAATTCTATTGACCCAGCCTTAATATCAAAATATCGGATCCCCGGGTTAATTAA-3' and 5'-TTAAACGTGATACCGTTTTAATGAGTTGAAAACTAAATAAGAATTCGAGCTCGTTTAAAC-3'. The AFT1-3HA PCR products were transformed into BY4742 and those of AFT2-3HA were transformed into BY4741 to generate strains SCMC05 and SCMC11. Strains SCMC18, SCMC10, and SCMC13 were isolated after mating strains SCMC11 and BY4742, SCMC05 and Y01090, and SCMC11 and Y14438, respectively. Epitope-tagged strains were verified by PCR, sequencing, and protein synthesis. The plasmids pEG202-AFT1 and pEG202-AFT2 have been described previously (3). Plasmid pFC-W was kindly provided by Y. Yamaguchi-Iwai; it contains the 263/234 upstream activation sequence of the FET3 gene that has been inserted into the CYC1 promoter and fused to the lacZ gene (38). Plasmids pFC-M1, pFC-M2, and pFC-M3, containing site-directed nucleotide substitutions introduced into the FET3 core sequence (252/243) to resemble to the SMF3 sequence (362/353), were constructed as follows. The entire SalI-BamHI fragment from the pFC-W was first subcloned into the pUC-18 vector (Stratagene), and the resulting plasmid was used as a PCR template for the QuikChange mutagenesis kit (Stratagene) according to the manufacturer's instructions. The primers used were 5'-GGCTCGACCTTCAAAACCGCACCCATTTGCAGGTGC-3' and its complement for M1 substitutions, 5'-CCTTCAAAAGTGCACCCTGTTGCAGGTGCTCGTCG-3' and its complement for M2 substitutions, and 5'-GGCTCGACCTTCAAAACCGCACCCTGTTGC-AGGTGCTCGTCG-3' and its complement for M3 substitutions. Then the entire SalI-BamHI fragment from the pUC-18 vector was reinserted into the SalI-BamHI sites of the pFC-W vector to obtain the pFC-M1, pFC-M2, and pFC-M3 plasmids. All PCR-generated sequences were confirmed by DNA sequencing.
|
RNA isolation, Northern analysis, and ß-galactosidase assay. Total RNA extraction, Northern blotting (15 µg total RNA), and hybridization were performed in duplicate, as described previously (14, 31). The 32P-labeled DNA fragments used as probes corresponded to the open reading frame of each gene. A 1.2-kb BamHI-HindIII fragment was used for the ACT1 gene. The 623-bp fragment of FET3, the 759-bp fragment of FTR1, the 744-bp fragment of MRS4, and the 924-bp fragment of SMF3 were obtained by PCR using the primer sets listed in Table 2. The membranes were exposed for 2 days. Data were quantified using ImageQuant software and normalized using the ACT1 mRNA signal. ß-Galactosidase was assayed using o-nitrophenyl-D-galactopyranoside (11).
|
alok/TreeView) was used to visualize the clustered data. Multiple expectation maximization for motif elicitation (MEME) (2) was used to identify shared motifs in the 700 bp of the promoters of similarly regulated genes. Additional information and a version of MEME running on a parallel supercomputer are available at http://meme.sdsc.edu/meme/website/intro.html. Chromatin immunoprecipitation. Cells were grown exponentially in 100 ml iron-depleted or iron-replete medium to an OD600 of 1. The chromatin was then prepared (15), and the resulting supernatant volume was adjusted to 4 ml before storage at 80°C. Immunoprecipitations were performed in duplicate. Five hundred microliters of the cross-linked chromatin solution was added to 8 µg of anti-HA monoclonal antibodies (Santa Cruz Biotechnology) prebound to 10 mg protein A-Sepharose CL-4B (Sigma) and incubated for 1.5 h at room temperature. Protein A-Sepharose CL-4B without antibody was used for background control. Beads were washed twice with 1.6 ml FA lysis buffer (15) with 500 mM NaCl; once with 1.6 ml 10 mM Tris-HCl, pH 8, 0.25 mM LiCl, 1 mM EDTA, 0.5% NP-40, and 0.5% sodium deoxycholate; and once with 1.6 ml Tris-EDTA, for 15 min each. Chromatin complexes were released from the beads by incubation in 500 µl of 25 mM Tris-HCl, pH 7.5, 10 mM EDTA, and 0.5% sodium dodecyl sulfate for 15 min at 65°C. Cross-links from eluates and crude chromatin solution (50 µl) were reversed by incubation with 600 µg proteinase K (Sigma) for 1 h at 37°C and overnight at 65°C. The resulting DNA was purified on PCR purification kit columns (QIAGEN).
Real-time quantitative PCR analysis. The QIAGEN Quantitect SYBR Green PCR kit was used for quantitative real-time PCR in a LightCycler (Roche Diagnostics). Primer pairs (Table 2) were designed with Oligo 4.0-s software to generate products of 90 to 130 bp. For the FET3, SMF3, and MRS4 promoters, PCR fragments were amplified with primers flanking the iron regulatory sites defined by promoter deletion analyses (23, 30, 38). For the FTR1 promoter, we designed primers to amplify the region (190 bp) between the two TGCACCC sequences. For POL1 and RPO21, used as negatives controls, we designed primers within their coding sequences.
PCRs were carried out in 15-µl reaction mixtures with 2 µM concentrations of each primer and 1x Quantitect SYBR Green PCR kit. The DNA templates added to the reaction mixture were 1/150 of the immunoprecipitated or background DNA and 1/50,000 of the input DNA. The LightCycler protocol was denaturation at 95°C for 15 min, 45 cycles of amplification and quantification (95°C for 20 s, 55°C for 20 s, 72°C for 25 s, with a single measurement), and a melting curve of 60 to 95°C, with a heating rate of 0.1°C per second and continuous fluorescence measurement.
Data were analyzed using the Roche LightCycler 3.5 software and the fit point method. The crossing point (CP) was defined as the point at which the fluorescence was 10 times the background fluorescence. The efficiency (E) of each primer pair was calculated from the slope of the linear standard curve (E = 101/slope) generated with a fivefold dilution of a DNA input mix. The protein occupancy of each DNA fragment was then calculated as previously described (4): protein occupancy = E(CP input CP immunoprecipitation)/E(CP input CP background). The data were averaged over two independent experiments, with real-time PCR performed at least in duplicate. The relative enrichment of a selected DNA fragment was obtained by dividing the protein occupancy at this DNA fragment by the average protein occupancy at the negative controls (coding sequences of POL1 and RPO21).
Protein extraction and Western blotting. Total protein extracts from 3 ml of cells grown exponentially in iron-depleted or iron-replete media were prepared by the NaOH-trichloroacetic acid lysis technique (36). Aliquots (5 µl) were separated on an 8% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gel and transferred to nitrocellulose membranes. The membranes were blocked with 3% bovine serum albumin (Sigma), 0.1% Tween 20 (Sigma) in Tris-buffered saline and probed at room temperature in the same blocking buffer. Anti-HA monoclonal antibodies (Santa Cruz Biotechnology) were diluted at 1:1,000, and anti-Pgk1 monoclonal antibodies (Roche Diagnostics) were diluted at 1:5,000. Horseradish peroxidase-conjugated anti-mouse immunoglobulin G (diluted 1:1,000) was used as the secondary antibody (Sigma) and was detected by enhanced chemiluminescence (ECL kit; Amersham).
| RESULTS |
|---|
|
|
|---|
|
The MEME program (2) was used to identify potential regulatory elements in the promoters of the genes regulated by Aft1 and Aft2. The promoter region between the predicted ATG start codon and 700 bp upstream was chosen to identify the most probable motif within each class, A to E, of input promoters (Fig. 1 and 2). MEME successfully identified the canonical iron-responsive element (38) TGCACCC in the promoters of the A and B class genes (Fig. 2). Thus, 13 of the 19 genes (68%) analyzed contained at least one copy of this sequence in either orientation. Analysis of the whole genome identified 3% of all open reading frames having this sequence within their promoter. There was also generally an A 2 bases upstream of the TGCACCC sequence. In contrast, the sequence TGCACCC was present in only 6 of the 22 class C and D gene promoters (27%). The most probable motif identified within the promoters of class C and D genes was restricted to G/ACACCC, with 20 of the 22 genes (91%) containing at least one copy of this motif. This sequence was present in 24% of the promoters of the whole genome. About 80% of the class C genes contained the G/ACACCC sequence followed by an AT-rich region starting 3 bases downstream the motif. MEME identified the GCACCCT sequence as the most probable motif of the class E genes; it was present in 44% of the genes analyzed (4 of 9 genes) and in 3.2% of the promoters of the whole genome. This sequence was often preceded by a T, reminiscent of the known TGCACCC sequence.
|
Direct activation of FET3 transcription by Aft1 but not by Aft2.
In vivo DNA footprint analyses have shown that Aft1 binds to the FET3 FeRE sequence and activates its transcription in an iron-dependent manner (37, 38). In contrast, the role of Aft2 in the transcriptional activation of FET3 is not clear. Aft2 binds to the same FET3 FeRE sequence as Aft1 in vitro (29), but Aft2-dependent regulation of FET3 in vivo has only been reported for specific conditions, such as overexpression of AFT2 in the absence of Aft1 (3) or expression of the constitutive allele AFT2-1up (29, 30). Northern blot analyses (Fig. 3A) confirmed that the transcription of FET3 required AFT1 but not AFT2 (3). Overexpression of AFT2 in aft1
aft2
increased the amount of FET3 mRNA, although this was still lower than that resulting from overexpression of AFT1. The amount of FET3 mRNA increased 1.5-fold in the absence of Aft2. ChIP analyses showed that Aft1 was strongly bound to the FET3 promoter in wild-type cells, whereas Aft2 was not (Fig. 3B). The occupancy of the FET3 promoter by Aft1 also increased 1.3-fold in the absence of Aft2. Conversely, low but reproducible amounts of Aft2 were bound to the FET3 promoter in the absence of Aft1, although this appeared to be insufficient to sustain observable FET3 mRNAs production (Fig. 3A and B). We further investigated the effect of iron on FET3 transcription and on the binding of Aft1/Aft2 to the FET3 promoter. Transcription of FET3 was repressed by adding iron (Fig. 3C), as previously reported (37). However, residual FET3 mRNAs were still detected in the wild-type and aft2
strains. ChIP assays indicated that iron decreased Aft1 binding to the FET3 promoter fivefold, but it was still four- to fivefold higher than the binding to nonrelevant DNA controls (Fig. 3D). The weak binding of Aft2 to the FET3 promoter in the absence of Aft1 was repressed by iron. Thus, Aft2 does not activate the transcription of FET3, although it can poorly bind to the FET3 promoter in the absence of Aft1, and FET3 is specifically activated by Aft1 under iron depletion.
|
, and aft2
strains were similar, while no transcript was detected in the aft1
aft2
double mutant (Fig. 4A). Overexpression of AFT2 induced the expression of FTR1 but to a lesser extent than overexpression of AFT1, in agreement with previous DNA microarray data obtained with the constitutive AFT1-1up/AFT2-1up alleles (29, 30, 33). ChIP experiments showed that Aft1 was bound to the FTR1 promoter in the wild-type and aft2
strains under iron-depleted conditions (Fig. 4B). The Aft1 occupancy of the FTR1 promoter was increased twofold in the absence of Aft2. Aft2 was also bound to the FTR1 promoter but only in the absence of Aft1. Aft1 and Aft2 occupied the FTR1 promoter similarly in the absence of their paralog, consistent with the similar amounts of FTR1 mRNAs found in the aft1
and aft2
mutants (Fig. 3A and B). These analyses indicate that Aft2 can compensate for the absence of Aft1 in the direct control of FTR1 transcription. We also investigated the effect of iron on the Aft1- and Aft2-dependent regulation of FTR1. The transcription of FTR1 decreased in iron-replete conditions, as previously reported (38). However, there was still residual transcription of FTR1 in the wild-type and aft2
strains, but not in the aft1
mutant (Fig. 4C). The degree of FTR1 promoter occupancy by Aft1 was two- to fourfold lower than under iron-depleted conditions, but it was still twofold higher than for DNA controls, whereas occupancy of the FTR1 promoter by Aft2 in the aft1
mutant was sevenfold lower, reaching the level of the DNA controls (Fig. 4D). Therefore, the binding of Aft2 to the FTR1 promoter is more sensitive to iron than is the binding of Aft1.
|
aft2
mutant (23). Our DNA microarray analysis indicated that the amount of SMF3 mRNAs in aft1
was greater than in the wild type, although it was lower than in the wild type in aft1
aft2
(Fig. 1). Northern blot analyses and ChIP experiments were performed to elucidate the antagonistic effect of the AFT1 deletion in wild-type versus aft2
genetic contexts. The amount of SMF3 mRNAs in the aft1
mutant was higher than in the wild type, consistent with the DNA microarray data, while it was slightly lower than in the wild type in the aft2
mutant (Fig. 5A). The effect of the AFT2 deletion was epistatic on that of the AFT1 deletion, since the amount of SMF3 mRNAs in the double aft1
aft2
mutant was lower than in the wild-type strain. The signal still detected in aft1
aft2
confirmed that other factors are involved in the activation of SMF3 transcription. Finally, overexpression of either AFT1 or AFT2 in the aft1
aft2
mutant clearly induced SMF3 expression. The occupancy of the SMF3 promoter by Aft1 was only 1.8-fold greater than in the DNA controls in aft2
and 2.7-fold greater than in the DNA controls in the wild-type strain (Fig. 5B). In contrast, a great deal of Aft2 (12 times more than in the DNA controls) was bound to the SMF3 promoter in the absence of Aft1. No Aft2 was bound to the SMF3 promoter in wild-type cells, as for FET3 and FTR1. This suggests that the increased SMF3 mRNA in aft1
was due to the direct binding of Aft2 and its activation of transcription. We checked this by investigating the Aft1-dependent and Aft2-dependent transcription of SMF3 in the presence of iron. The experiments performed in iron-replete conditions showed correlated decreases in both the amount of SMF3 mRNA (threefold) and the occupancy of the SMF3 promoter by Aft2 in the aft1
mutant (fivefold) (Fig. 5C and D). It also showed that the low occupancy of the SMF3 promoter by Aft1 was affected by iron. We conclude that Aft2 directly activates the transcription of SMF3 when Aft1 is absent.
|
mutant than in the wild-type strain (7). Our DNA microarray data (Fig. 1) and Northern blot analyses (Fig. 6A) confirmed the latter result. Moreover, the introduction of a plasmid carrying AFT1 into the aft1
mutant led to a decrease in the MRS4 mRNAs (Fig. 6A). The amount of MRS4 mRNA was not affected by sole deletion of AFT2, but the increased amount of MRS4 mRNA in the aft1
mutant was suppressed by deleting AFT2 as well. The remaining signal in the aft1
aft2
mutant indicated that other factors are involved in activating MRS4 transcription. These results suggest that the increased transcription of MRS4 in the aft1
mutant is due to Aft2, as for SMF3. Considerable amounts of Aft2 were consistently bound to the MRS4 promoter in the absence of Aft1 (27.5-fold more than to the DNA controls) (Fig. 6B). Little Aft2 was bound to the MRS4 promoter in wild-type cells (two times more than bound to the DNA controls). No Aft1 was bound to the MRS4 promoter in the wild-type or aft2
strains, unlike Aft2. The amounts of MRS4 mRNAs were greatly reduced in the absence of Aft1 under iron-replete conditions (Fig. 6C). In agreement with this decreased MRS4 mRNA amount, the binding of Aft2 to the MRS4 promoter was 15 times less than under iron limitation (Fig. 6D). Thus, Aft2 directly activates the transcription of MRS4 in iron-depleted conditions when Aft1 is absent. Control experiments indicated that there was no binding of Aft2 in a wild-type strain grown with iron, regardless of the promoter studied (FET3, FTR1, SMF3, or MRS4) (data not shown).
|
, aft2
, and aft1
aft2
strains. These plasmids were also used to transform the aft1
aft2
strain harboring a high-copy-number plasmid which overexpressed either AFT1 or AFT2. We evaluated the Aft1 and Aft2 transcriptional activity from the mutated promoters by comparing the ß-galactosidase activities in these strains. The ß-galactosidase activities obtained with the pFC-W plasmid in the different genetic contexts (Fig. 7B) confirmed previous data showing that the transcription of FET3 is predominantly Aft1 dependent (3). The slightly higher ß-galactosidase activity in aft2
than in the wild-type strain is in agreement with the increased FET3 mRNA (Fig. 3A). The ß-galactosidase activity obtained with pFC-M1 was 3.5-fold lower than that obtained with the pFC-W plasmid in the wild-type strain, 2.5-fold lower than that obtained with pFC-M2, and 6.6-fold lower than that obtained with pFC-M3. Similar results were obtained in the aft2
strain. These results indicate that Aft1 is a poor activator for the mutated promoters and that Aft2 is not involved in the residual activation when Aft1 is present. No significant ß-galactosidase activity was detected in the aft1
aft2
mutant transformed with the pFC-W, pFC-M1, pFC-M2, or pFC-M3 plasmid, indicating that the ß-galactosidase activity mediated by these plasmids was strictly Aft1/2 dependent. The ß-galactosidase activity measured in the aft1
mutant, attributed to Aft2, was 3.5-fold higher than that of the aft1
aft2
mutant with pFC-W. The Aft2-dependent activation was more efficient in the pFC-M1 context (2.3-fold greater than pFC-W); in contrast, this Aft2-dependent activation was lower (1.7-fold decrease) with pFC-M2 than with pFC-W and remained unchanged with pFC-M3. The ß-galactosidase activities measured with pFC-W, pFC-M1, pFC-M2, and pFC-M3 were decreased three- to fourfold by adding 100 µM iron in the wild type, aft2
, and aft1
strains (data not shown). The differences in Aft1- and Aft2-dependent activation were further confirmed with aft1
aft2
strains overexpressing either the AFT1 or AFT2 gene (Fig. 7B). Overexpression of AFT2 increased the transcription from the pFC-M1 promoter 2.4-fold and from the pFC-M3 promoter 2.6-fold, while it decreased the transcription from pFC-M2 1.9-fold compared to pFC-W. The transcription from pFC-M1, pFC-M2, and pFC-M3 was lower than with pFC-W when AFT1 was overexpressed.
|
or aft1
cells grown in iron-depleted and in iron-replete conditions by Western blotting with anti-HA antibody to determine whether these effects resulted from changes in the amounts of Aft1 and Aft2 proteins. The concentration of Aft1 was higher in the absence of Aft2 than in the wild type under iron depletion (Fig. 8A); this is in agreement with the increased Aft1-mediated activation of FET3 and FTR1 transcription in the aft2
strain (Fig. 3 and 4). The amount of Aft1 in wild-type cells was not greatly affected by adding iron, consistent with previous analyses (39). Nevertheless, it was decreased at least twofold by iron in the absence of Aft2. Analysis of the amounts of Aft2 showed a weak band corresponding to Aft2, fainter than that of Aft1 in wild-type cells (Fig. 8B). The amount of Aft2 was 3.3-fold higher in the absence of Aft1 under iron-depleted conditions, in agreement with the stimulation of the Aft2-activated transcription alone under these conditions (Fig. 3 to 6). The amount of Aft2 in wild-type cells was not affected by adding iron, while it was decreased by iron in the absence of the paralog, as was that of Aft1. The Western blot analyses therefore show that the amounts of Aft1 and Aft2 are increased in the absence of the paralog under iron depletion and that iron represses the amounts Aft1 and Aft2 in these genetic contexts.
|
| DISCUSSION |
|---|
|
|
|---|
The detailed study by Northern blotting and ChIP experiments of the prototype genes FET3, FTR1, SMF3, and MRS4, representing the four A, B, C, and D class genes, respectively, has provided new insights into the direct and indirect actions of Aft1 and Aft2 in the regulation of genes involved in iron homeostasis. The degrees of promoter occupancy by Aft1 and Aft2 were correlated with the subsequent transcription of the corresponding genes. A striking feature here is that Aft1 and Aft2 mostly activate distinct iron-regulated genes in vivo by selective binding to the promoter, while they are able to bind to the same sequence in vitro (29). Aft1 binds well to FET3 and FTR1 promoters and poorly to the SMF3 promoter, but Aft1 is not bound to the MRS4 promoter; conversely, Aft2 binds poorly to the FET3 promoter and well to the FTR1, SMF3, and MRS4 promoters (summarized in Fig. 9A). This raises the question of how Aft1 and Aft2 identify the appropriate promoters. A search for specific cis-acting sequences in the promoter regions of class A and B genes activated by Aft1 identified the canonical TGCACCC sequence of the defined FeRE element (38), indicating the importance of this sequence in the Aft1-mediated activation. In contrast, we observed that the consensus sequence in the promoter regions of genes specifically activated by Aft2 (classes C and D) was not the TGCACCC sequence, but the shorter G/ACACCC sequence (Fig. 2). Hence, the TGCACCC sequence appears to be important for Aft1-mediated activation, but not for Aft2-mediated activation. This was confirmed by transcriptional analysis of a LacZ reporter gene cloned under the control of variants of the FET3 GTGCACCCAT iron-responsive element. Changing the 5' GT to CC dramatically decreased Aft1-dependent activation. Changing the 3' AT to TG also affected the Aft1-mediated activation by decreasing the transcription of LacZ, but to a lesser extent than the previous mutation. Introducing both changes in the 5' and 3' of the FET3 iron-responsive element led to a cumulated loss of Aft1-mediated transcription. By contrast with Aft1 reactivity, the 5' variant FET3 CCGCACCCAT element supported increased Aft2-mediated activation. Although the activation measured with the natural amount of Aft2 was low, it was significant, and overexpression of AFT2 confirmed that this 2-bp change is critical for increased activation. Changing only the 3' end of the site (AT to TG) decreased the Aft2-mediated activation. The two mutations led to an overall increased activation when AFT2 was overexpressed. Our results on Aft1-mediated activation agree well with previous DNA binding competition experiments demonstrating that the in vitro-translated Aft1 protein interacted better with the TGCACCCA sequence than with the sequences GGCACCCA or TGCACCCC (38). The new data we provided on Aft2-mediated activation are also in accordance with in vivo analyses of lacZ reporter fusion constructs showing (i) that iron regulation of the Aft2-activated gene SMF3 depends on the 361CGCACCC sequence and not on the 430TGCACCC sequence (22) and (ii) that the AFT2-1up allele activates the transcription of MRS4 through the 238GGCACCC sequence (30). Taken together, our computer analysis of the iron-responsive elements of the Aft1- and Aft2-regulated genes and transcriptional analysis of the FET3 promoter LacZ fusion provide strong support for differently defined Aft1 and Aft2 DNA binding sites; Aft1 appears to be more selective in recognizing the 5' context of the GCACCC sequence than is Aft2. However, the presence of the TGCACCC sequence in the promoter region of a gene is not sufficient for its activation by Aft1 because some class C, D, and E genes contain the TGCACCC sequence in their promoter regions and are not activated by Aft1 (Fig. 1 to 2). Thus, Aft1 (and Aft2) may recognize the promoter through combination with other trans-acting factors in addition to the specific regulatory cis-acting sequence. Recent studies have shown that the HMG box chromatin-associated architectural factor Nhp6 associates with Aft1 in vivo to facilitate its recruitment to the promoter region of certain of the Aft1-activated genes (8).
|
Phenotype analyses have shown that the sole AFT2 deletion confers no iron-specific phenotype, whereas it reveals misregulation of intracellular iron use and oxidative stress-related phenotypes in the absence of Aft1 (3). Consistently, we have now shown that the Aft2-mediated activation of transcription is revealed under iron-depleted conditions and in the absence of Aft1. This suggests that the Aft2 activity is triggered by exacerbated iron-limiting conditions caused by the cumulative effects of environmental iron depletion and a lack of Aft1-dependent iron uptake systems. Thus, in response to severe iron limitation, the activation by Aft2 of the transcription of genes involved in vacuolar and mitochondrial iron transport may lead to a reorganization of the intracellular iron distribution. This is further supported by recent data indicating that the Aft2 target gene MRS4 is involved in a mitochondrial-vacuolar iron-signaling pathway (19). A hierarchical model implicating Aft1 and Aft2 in a graded response to iron limitation fits well with the greater sensitivity of Aft2 to iron: a given iron concentration in the culture medium may completely abolish the binding of Aft2 to DNA but only decrease that of Aft1. Further investigation is now required to clarify the fine-tuning of Aft2 triggering in response to iron limitation.
The absence of one of the Aft1/Aft2 paralogs under iron deprivation conditions leads to an increase in the binding of the resident paralog to its specific promoters and subsequent gene activation (Fig. 3 to 6). These effects are correlated with a change in the abundance of paralog protein in whole cells (Fig. 8 and 9B). The extent to which the absence of either Aft1 or Aft2 increases the amount of the remaining paralog protein varies: the Aft2 concentration increases more in the absence of Aft1 than does that of Aft1 in the absence of Aft2. The reciprocal negative influence of Aft1 and Aft2 may reflect a compensatory mechanism to counterbalance a failure in processes regulated by one factor by stimulating those of the paralog. This would allow the cell to tightly coordinate the Aft1-mediated regulation of extracellular iron transport and the Aft2-mediated regulation of iron intracellular use.
The modulation of protein amounts may involve transcriptional and/or posttranscriptional regulation. Aft1 binds to its own promoter (16). We found 614TGCACCC and 658GGCACCC sequences in the AFT1 promoter. This suggests that Aft1 and Aft2 are directly involved in the regulation of AFT1 transcription. In contrast, no CACCC core element of the FeRE sequence was found in the AFT2 promoter. Any change in its transcription in response to AFT1 deletion would thus occur through other cis- and trans-regulatory elements. Posttranslational effects may also be involved. Our data agree with recent work on mammals showing that the amount of the iron-regulatory protein IRP2 is increased when the paralog gene encoding IRP1 is deleted. Since iron regulates IRP2 by mediating its proteasomal degradation, these experiments suggest that IRP1 is involved in this step of regulation (22). We show that the negative effect of Aft1 and Aft2 on the amount of the paralog is iron dependent. How iron is involved in controlling the balance between the Aft1 and Aft2 proteins is still unknown, and answering this question is critical for a better understanding of the functions of these iron-responsive paralogous transcription factors in the yeast cell. Iron regulates the function of Aft1 by modulating its subcellular distribution (39) but is likely to be involved at other steps of Aft1 control. Nothing is yet known about the regulation of Aft2 function by iron. As a first step toward clarifying this critical point, experiments are in progress to determine the level at which iron regulates Aft2 abundance in the absence of Aft1.
| ACKNOWLEDGMENTS |
|---|
This work was supported by grants from the Ministère de la Recherche (Programme de Recherches Fondamentales en Microbiologie, Maladies Infectieuses et Parasitaires), the Association pour la Recherche sur le Cancer (ARC no. 5439), and the Centre National pour la Recherche Scientifique (grant from the Programme de Toxicologie Nucléaire).
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
2. Bailey, T. L., and C. Elkan. 1994. Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proc. Int. Conf. Intell. Syst. Mol. Biol. 2:28-36.[Medline]
3. Blaiseau, P. L., E. Lesuisse, and J. M. Camadro. 2001. Aft2p, a novel iron-regulated transcription activator that modulates, with Aft1p, intracellular iron use and resistance to oxidative stress in yeast. J. Biol. Chem. 276:34221-34226.
4. Cobb, J. A., L. Bjergbaek, K. Shimada, C. Frei, and S. M. Gasser. 2003. DNA polymerase stabilization at stalled replication forks requires Mec1 and the RecQ helicase Sgs1. EMBO J. 22:4325-4336.[CrossRef][Medline]
5. Dancis, A., R. D. Klausner, A. G. Hinnebusch, and J. G. Barriocanal. 1990. Genetic evidence that ferric reductase is required for iron uptake in Saccharomyces cerevisiae. Mol. Cell. Biol. 10:2294-2301.
6. Eisen, M. B., P. T. Spellman, P. O. Brown, and D. Botstein. 1998. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95:14863-14868.
7. Foury, F., and T. Roganti. 2002. Deletion of the mitochondrial carrier genes MRS3 and MRS4 suppresses mitochondrial iron accumulation in a yeast frataxin-deficient strain. J. Biol. Chem. 277:24475-24483.
8. Fragiadakis, G. S., D. Tzamarias, and D. Alexandraki. 2004. Nhp6 facilitates Aft1 binding and Ssn6 recruitment, both essential for FRE2 transcriptional activation. EMBO J. 23:333-342.[CrossRef][Medline]
9. Garland, S. A., K. Hoff, L. E. Vickery, and V. C. Culotta. 1999. Saccharomyces cerevisiae ISU1 and ISU2: members of a well-conserved gene family for iron-sulfur cluster assembly. J. Mol. Biol. 294:897-907.[CrossRef][Medline]
10. Georgatsou, E., and D. Alexandraki. 1999. Regulated expression of the Saccharomyces cerevisiae Fre1p/Fre2p Fe/Cu reductase related genes. Yeast 15:573-584.[CrossRef][Medline]
11. Guarente, L. 1983. Yeast promoters and lacZ fusions designed to study expression of cloned genes in yeast. Methods Enzymol. 101:181-191.[Medline]
12. Hantke, K. 2001. Iron and metal regulation in bacteria. Curr. Opin. Microbiol. 4:172-177.[CrossRef][Medline]
13. Hentze, M. W., M. U. Muckenthaler, and N. C. Andrews. 2004. Balancing acts: molecular control of mammalian iron metabolism. Cell 117:285-297.[CrossRef][Medline]
14. Kohrer, K., and H. Domdey. 1991. Preparation of high molecular weight RNA. Methods Enzymol. 194:398-405.[Medline]
15. Kuras, L., and K. Struhl. 1999. Binding of TBP to promoters in vivo is stimulated by activators and requires Pol II holoenzyme. Nature 399:609-613.[CrossRef][Medline]
16. Lee, T. I., N. J. Rinaldi, F. Robert, D. T. Odom, Z. Bar-Joseph, G. K. Gerber, N. M. Hannett, C. T. Harbison, C. M. Thompson, I. Simon, J. Zeitlinger, E. G. Jennings, H. L. Murray, D. B. Gordon, B. Ren, J. J. Wyrick, J. B. Tagne, T. L. Volkert, E. Fraenkel, D. K. Gifford, and R. A. Young. 2002. Transcriptional regulatory networks in Saccharomyces cerevisiae. Science 298:799-804.
17. Lesuisse, E., P. L. Blaiseau, A. Dancis, and J. M. Camadro. 2001. Siderophore uptake and use by the yeast Saccharomyces cerevisiae. Microbiology 147:289-298.
18. Lesuisse, E., M. Simon-Casteras, and P. Labbe. 1998. Siderophore-mediated iron uptake in Saccharomyces cerevisiae: the SIT1 gene encodes a ferrioxamine B permease that belongs to the major facilitator superfamily. Microbiology 144:3455-3462.[Abstract]
19. Li, L., and J. Kaplan. 2004. A mitochondrial-vacuolar signaling pathway in yeast that affects iron and copper metabolism. J. Biol. Chem. 279:33653-33661.
20. Longtine, M. S., A. McKenzie III, D. J. Demarini, N. G. Shah, A. Wach, A. Brachat, P. Philippsen, and J. R. Pringle. 1998. Additional modules for versatile and economical PCR-based gene deletion and modification in Saccharomyces cerevisiae. Yeast 14:953-961.[CrossRef][Medline]
21. Martins, L. J., L. T. Jensen, J. R. Simon, G. L. Keller, D. R. Winge, and J. R. Simons. 1998. Metalloregulation of FRE1 and FRE2 homologs in Saccharomyces cerevisiae. J. Biol. Chem. 273:23716-23721.
22. Meyron-Holtz, E. G., M. C. Ghosh, K. Iwai, T. LaVaute, X. Brazzolotto, U. V. Berger, W. Land, H. Ollivierre-Wilson, A. Grinberg, P. Love, and T. A. Rouault. 2004. Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis. EMBO J. 23:386-395.[CrossRef][Medline]
23. Portnoy, M. E., L. T. Jensen, and V. C. Culotta. 2002. The distinct methods by which manganese and iron regulate the Nramp transporters in yeast. Biochem. J. 362:119-124.[CrossRef][Medline]
24. Portnoy, M. E., X. F. Liu, and V. C. Culotta. 2000. Saccharomyces cerevisiae expresses three functionally distinct homologues of the nramp family of metal transporters. Mol. Cell. Biol. 20:7893-7902.
25. Protchenko, O., T. Ferea, J. Rashford, J. Tiedeman, P. O. Brown, D. Botstein, and C. C. Philpott. 2001. Three cell wall mannoproteins facilitate the uptake of iron in Saccharomyces cerevisiae. J. Biol. Chem. 276:49244-49250.
26. Protchenko, O., and C. C. Philpott. 2003. Regulation of intracellular heme levels by HMX1, a homologue of heme oxygenase, in Saccharomyces cerevisiae. J. Biol. Chem. 278:36582-36587.
27. Puig, S., E. Askeland, and D. J. Thiele. 2005. Coordinated remodeling of cellular metabolism during iron deficiency through targeted mRNA degradation. Cell 120:99-110.[CrossRef][Medline]
28. Rutherford, J. C., and A. J. Bird. 2004. Metal-responsive transcription factors that regulate iron, zinc, and copper homeostasis in eukaryotic cells. Eukaryot. Cell 3:1-13.
29. Rutherford, J. C., S. Jaron, E. Ray, P. O. Brown, and D. R. Winge. 2001. A second iron-regulatory system in yeast independent of Aft1p. Proc. Natl. Acad. Sci. USA 98:14322-14327.
30. Rutherford, J. C., S. Jaron, and D. R. Winge. 2003. Aft1p and Aft2p mediate iron-responsive gene expression in yeast through related promoter elements. J. Biol. Chem. 278:27636-27643.
31. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
32. Schilke, B., C. Voisine, H. Beinert, and E. Craig. 1999. Evidence for a conserved system for iron metabolism in the mitochondria of Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 96:10206-10211.
33. Shakoury-Elizeh, M., J. Tiedeman, J. Rashford, T. Ferea, J. Demeter, E. Garcia, R. Rolfes, P. O. Brown, D. Botstein, and C. C. Philpott. 2004. Transcriptional remodeling in response to iron deprivation in Saccharomyces cerevisiae. Mol. Biol. Cell 15:1233-1243.
34. Stearman, R., D. S. Yuan, Y. Yamaguchi-Iwai, R. D. Klausner, and A. Dancis. 1996. A permease-oxidase complex involved in high-affinity iron uptake in yeast. Science 271:1552-1557.[Abstract]
35. Urbanowski, J. L., and R. C. Piper. 1999. The iron transporter Fth1p forms a complex with the Fet5 iron oxidase and resides on the vacuolar membrane. J. Biol. Chem. 274:38061-38070.
36. Volland, C., D. Urban-Grimal, G. Geraud, and R. Haguenauer-Tsapis. 1994. Endocytosis and degradation of the yeast uracil permease under adverse conditions. J. Biol. Chem. 269:9833-9841.
37. Yamaguchi-Iwai, Y., A. Dancis, and R. D. Klausner. 1995. AFT1: a mediator of iron regulated transcriptional control in Saccharomyces cerevisiae. EMBO J. 14:1231-1239.[Medline]
38. Yamaguchi-Iwai, Y., R. Stearman, A. Dancis, and R. D. Klausner. 1996. Iron-regulated DNA binding by the AFT1 protein controls the iron regulon in yeast. EMBO J. 15:3377-3384.[Medline]
39. Yamaguchi-Iwai, Y., R. Ueta, A. Fukunaka, and R. Sasaki. 2002. Subcellular localization of Aft1 transcription factor responds to